Skip to main content
Featured NewsNews

Wall Street Journal: Harvard Spinout Sets Sights on Huge Drug Market

By September 28, 2017November 9th, 2021No Comments

Venture investors seed GRO Biosciences’ quest for improved protein drugs

By Brian Gormley

GRO Biosciences Inc. wants to make a giant sector in the pharmaceutical industry even larger.

The spinout from the lab of Harvard Medical School geneticist George Church aims to make protein drugs more versatile and effective by recoding the genomes of bacterial strains used to make these biological medicines.

Insulin, human growth hormone…

To view original content click: